Therapy in hereditary angioneurotic oedema.
D000293:Adolescent; D000328:Adult; D000614:Aminocaproates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000799:Angioedema / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D002648:Child; D002986:Clinical Trials as Topic; D003165:Complement System Proteins / Q000032:analysis; D004950:Esterases / Q000037:antagonists & inhibitors; D006801:Humans; D005779:Immunodiffusion; D009120:Muscle Cramp / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D010375:Pedigree; D010919:Placebos; D014717:Vertigo / Q000139:chemically induced
D000614:Aminocaproates; D010919:Placebos; D003165:Complement System Proteins; D004950:Esterases